{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:10:38Z","timestamp":1775675438698,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd006628.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000}}],"reference-count":61,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006628.pub3","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T11:26:26Z","timestamp":1285673186000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Zotepine versus other atypical antipsychotics for schizophrenia"],"prefix":"10.1002","volume":"2012","author":[{"given":"Selvizhi","family":"Subramanian","sequence":"first","affiliation":[{"name":"Morecambe Community Mental Health Team; Psychiatry; Victoria House Thornton RD Morecambe UK LA4 5NN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Rummel-Kluge","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Hunger","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Schmid","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Kissling","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Komossa","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD006628.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-1000729","article-title":"Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients","volume":"59","author":"Klieser","year":"1991","journal-title":"Fortschritte der Neurologie und Psychiatrie"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0002|cit2","unstructured":"Chiu H-J Lin C-C Bai Y-M Chen J-Y Wang Y-C Lai I-C A randomized, single-blind study to evaluate the antipsychotic effect and safety of clozapine versus switching to zotepine in schizophrenic patients Proceedings of the12th World Congress of Psychiatry; 2002 Aug 24-29; Yokohama, Japan 2002"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/S0924-977X(03)92042-6","article-title":"Switching from clozapine to zotepine in schizophrenic patients: a randomized, single-blind controlled study","volume":"13","author":"Lin","year":"2003","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0004|cit4","first-page":"179","article-title":"Zotepine versus clozapine: a comparison of the impact on the cognitive dysfunction syndrome in schizophrenia (a double blind trial)","volume":"28","author":"Gallhofer","year":"1995","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-979481","article-title":"Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: Results from a double-blind study","volume":"30","author":"Meyer-Lindenberg","year":"1997","journal-title":"Pharmacopsychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD006628.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0920-9964(01)00322-X","article-title":"Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients","volume":"57","author":"Briken","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006628.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1016\/S0924-977X(06)70525-9","article-title":"Switching from other second generation antipsychotics to zotepine in schizophrenic patients: a 12-week open-label study","volume":"16","author":"Chen","year":"2006","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub3-BIB0008|cit8","first-page":"435","article-title":"Clinical effects of zotepine in outpatients with schizophrenia","volume":"22","author":"Hada","year":"1985","journal-title":"Shinryo to Shinyaku"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0009|cit9","first-page":"87","article-title":"Controlled clinical trial of zotepine in schizophrenia","volume":"1392","author":"Hen","year":"1987","journal-title":"Chinese Journal of Nervous and Mental Disorders"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub3-BIB0010|cit10","first-page":"1175","article-title":"Effects of zotepine in acute treatment and maintenance therapy of schizophrenic out-patients","volume":"18","author":"Komada","year":"1987","journal-title":"Igaku to Yakugaku"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006628.pub3-BIB0011|cit11","first-page":"S500","article-title":"Long-term outcome of switching from clozapine to zotepine in refractory schizophrenia: a 2-year follow-up study","volume":"15","author":"Lin","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD006628.pub3-BIB0012|cit12","first-page":"1205","article-title":"Effects of zotepine on chronic schizophrenics with a mean disease duration of 19.9 years","volume":"25","author":"Ohhara","year":"1988","journal-title":"Shinryo to Shinyaku"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Perro C Naber D Lambert M Moritz S Krause M A prospective clinical comparative-study of four atypical antipsychotic agents in the treatment of schizophrenia Proceedings of the 11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany 1999","DOI":"10.2165\/00128413-199912110-00012"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006628.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2007-1017125","article-title":"Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry","volume":"20","author":"Saletu","year":"1987","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1002\/14651858.CD006628.pub3-BIB0015|cit15","first-page":"2043","article-title":"Clinical use of zotepine (lodopin) for schizophrenia and mania","volume":"23","author":"Takashina","year":"1986","journal-title":"Shinryo to Shinyaku"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0016|cit16","unstructured":"Tsai C-J A multi-centre comparative study to evaluate the anti-aggression effect and safety of zotepine versus risperidone in aggressive schizophrenic patients in an acute ward http:\/\/www.clinicaltrials.gov 2007"},{"issue":"7066","key":"10.1002\/14651858.CD006628.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423363.45859","volume-title":"Treatment of patients with schizophrenia","author":"Work Group on Schizophrenia","year":"2004"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub3-BIB0021|cit21","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0023|cit23","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa 2000"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub3-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001948.pub2","article-title":"Zotepine for schizophrenia","author":"DeSilva","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub3-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub3-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004578.pub3","article-title":"Aripiprazole for schizophrenia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006628.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/978-3-642-46658-8_14","article-title":"A short cognitive performance test as an instrument for the assessment of clinical efficacy of cognitive enhancers","volume-title":"Diagnosis and Treatment of Senile Dementia","author":"Erzigkeit","year":"1989"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0033|cit33","volume-title":"Treatment guidelines for schizophrenia","author":"Gaebel","year":"2006"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine","volume":"163","author":"Heres","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration. Available from www.cochrane-handbook.org 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment of treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0040|cit40","first-page":"585","article-title":"Treatment programme and long term outcome in chronic schizophrenia","volume":"46","author":"Kane","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0041|cit41","volume-title":"Positive and negative syndrome scale (PANSS) manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF02245006","article-title":"Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors","volume":"112","author":"Leysen","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Liebermann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marvaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0049|cit49","first-page":"329","article-title":"New assessment of atypical antipsychotics","volume":"71","author":"M\u00f6ller","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0050|cit50","first-page":"123","article-title":"Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile","volume":"32","author":"Needham","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0053|cit53","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandanivia Suppl"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \"Just the facts\" What we know in 2008. 2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophrenia research"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006628.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0058|cit58","unstructured":"WHO Mental Health: New Understanding, New Hope The World Health report 2001"},{"key":"10.1002\/14651858.CD006628.pub3-BIB0059|cit59","unstructured":"Xia J Adams CE Bhagat N Bhagat V Bhoopathi P Pinfold V Takriti Y The Leeds Outcomes Stakeholders Survey (LOSS) Study Proceedings of the 15th Cochrane Colloquium; 2007 Oct 23-27; Sao Paulo The Cochrane Collaboration 2007"},{"issue":"1","key":"10.1002\/14651858.CD006628.pub3-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Zotepine versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-Analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"American Journal of Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006628.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:18:06Z","timestamp":1775672286000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006628.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006628.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,6]]}}}